 | • レポートコード：MRC2-11QY01554 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫学治療薬のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体（mAb）、抗体薬物複合体、インターフェロン・サイトカイン療法、免疫抑制薬）市場規模、用途別（病院、診療所、がん研究センター・研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫学治療薬の競争状況、市場シェア ・世界の免疫学治療薬市場：種類別市場規模 2015年-2020年（モノクローナル抗体（mAb）、抗体薬物複合体、インターフェロン・サイトカイン療法、免疫抑制薬） ・世界の免疫学治療薬市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体（mAb）、抗体薬物複合体、インターフェロン・サイトカイン療法、免疫抑制薬） ・世界の免疫学治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、がん研究センター・研究所） ・世界の免疫学治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん研究センター・研究所） ・北米の免疫学治療薬市場分析：米国、カナダ ・ヨーロッパの免疫学治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫学治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫学治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫学治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Active Biotech、Eli Lilly and Company、Autoimmune Inc.、Pfizer、GlaxoSmithKline plc、Seattle Genetics、Genentech、F. Hoffmann-La Roche Ltd.、Eisai Co.、Bayer AG、Sanofi Aventis LLC. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body’s healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
Market Analysis and Insights: Global Immunology Drug Market
The global Immunology Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Immunology Drug Scope and Market Size
Immunology Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Immunology Drug market is segmented into
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Segment by Application, the Immunology Drug market is segmented into
Hospitals
Clinics
Cancer Research Centers and Institutes
Regional and Country-level Analysis
The Immunology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunology Drug Market Share Analysis
Immunology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunology Drug business, the date to enter into the Immunology Drug market, Immunology Drug product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
1 Study Coverage
1.1 Immunology Drug Product Introduction
1.2 Market Segments
1.3 Key Immunology Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunology Drug Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies (mAb)
1.4.3 Antibody Drug Conjugates
1.4.4 Interferon and Cytokine therapies
1.4.5 Immunosuppressive medication
1.5 Market by Application
1.5.1 Global Immunology Drug Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers and Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunology Drug Market Size, Estimates and Forecasts
2.1.1 Global Immunology Drug Revenue 2015-2026
2.1.2 Global Immunology Drug Sales 2015-2026
2.2 Global Immunology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Immunology Drug Competitor Landscape by Players
3.1 Immunology Drug Sales by Manufacturers
3.1.1 Immunology Drug Sales by Manufacturers (2015-2020)
3.1.2 Immunology Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Immunology Drug Revenue by Manufacturers
3.2.1 Immunology Drug Revenue by Manufacturers (2015-2020)
3.2.2 Immunology Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2019
3.2.5 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Immunology Drug Price by Manufacturers
3.4 Immunology Drug Manufacturing Base Distribution, Product Types
3.4.1 Immunology Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunology Drug Product Type
3.4.3 Date of International Manufacturers Enter into Immunology Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunology Drug Market Size by Type (2015-2020)
4.1.1 Global Immunology Drug Sales by Type (2015-2020)
4.1.2 Global Immunology Drug Revenue by Type (2015-2020)
4.1.3 Immunology Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunology Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunology Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Immunology Drug Revenue Forecast by Type (2021-2026)
4.2.3 Immunology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunology Drug Market Size by Application (2015-2020)
5.1.1 Global Immunology Drug Sales by Application (2015-2020)
5.1.2 Global Immunology Drug Revenue by Application (2015-2020)
5.1.3 Immunology Drug Price by Application (2015-2020)
5.2 Immunology Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunology Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Immunology Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunology Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Immunology Drug by Country
6.1.1 North America Immunology Drug Sales by Country
6.1.2 North America Immunology Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Immunology Drug Market Facts & Figures by Type
6.3 North America Immunology Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Immunology Drug by Country
7.1.1 Europe Immunology Drug Sales by Country
7.1.2 Europe Immunology Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Immunology Drug Market Facts & Figures by Type
7.3 Europe Immunology Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Immunology Drug by Region
8.1.1 Asia Pacific Immunology Drug Sales by Region
8.1.2 Asia Pacific Immunology Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Immunology Drug Market Facts & Figures by Type
8.3 Asia Pacific Immunology Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Immunology Drug by Country
9.1.1 Latin America Immunology Drug Sales by Country
9.1.2 Latin America Immunology Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Immunology Drug Market Facts & Figures by Type
9.3 Central & South America Immunology Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Immunology Drug by Country
10.1.1 Middle East and Africa Immunology Drug Sales by Country
10.1.2 Middle East and Africa Immunology Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Immunology Drug Market Facts & Figures by Type
10.3 Middle East and Africa Immunology Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Immunology Drug Products Offered
11.1.5 Abbott Laboratories Related Developments
11.2 Active Biotech
11.2.1 Active Biotech Corporation Information
11.2.2 Active Biotech Description and Business Overview
11.2.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Active Biotech Immunology Drug Products Offered
11.2.5 Active Biotech Related Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Description and Business Overview
11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Company Immunology Drug Products Offered
11.3.5 Eli Lilly and Company Related Developments
11.4 Autoimmune Inc.
11.4.1 Autoimmune Inc. Corporation Information
11.4.2 Autoimmune Inc. Description and Business Overview
11.4.3 Autoimmune Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Autoimmune Inc. Immunology Drug Products Offered
11.4.5 Autoimmune Inc. Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Immunology Drug Products Offered
11.5.5 Pfizer Related Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Corporation Information
11.6.2 GlaxoSmithKline plc Description and Business Overview
11.6.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
11.6.5 GlaxoSmithKline plc Related Developments
11.7 Seattle Genetics
11.7.1 Seattle Genetics Corporation Information
11.7.2 Seattle Genetics Description and Business Overview
11.7.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Seattle Genetics Immunology Drug Products Offered
11.7.5 Seattle Genetics Related Developments
11.8 Genentech
11.8.1 Genentech Corporation Information
11.8.2 Genentech Description and Business Overview
11.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Genentech Immunology Drug Products Offered
11.8.5 Genentech Related Developments
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
11.9.5 F. Hoffmann-La Roche Ltd. Related Developments
11.10 Eisai Co.
11.10.1 Eisai Co. Corporation Information
11.10.2 Eisai Co. Description and Business Overview
11.10.3 Eisai Co. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eisai Co. Immunology Drug Products Offered
11.10.5 Eisai Co. Related Developments
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Immunology Drug Products Offered
11.1.5 Abbott Laboratories Related Developments
11.12 Sanofi Aventis LLC.
11.12.1 Sanofi Aventis LLC. Corporation Information
11.12.2 Sanofi Aventis LLC. Description and Business Overview
11.12.3 Sanofi Aventis LLC. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sanofi Aventis LLC. Products Offered
11.12.5 Sanofi Aventis LLC. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Immunology Drug Market Estimates and Projections by Region
12.1.1 Global Immunology Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Immunology Drug Revenue Forecast by Regions 2021-2026
12.2 North America Immunology Drug Market Size Forecast (2021-2026)
12.2.1 North America: Immunology Drug Sales Forecast (2021-2026)
12.2.2 North America: Immunology Drug Revenue Forecast (2021-2026)
12.2.3 North America: Immunology Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Immunology Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Immunology Drug Sales Forecast (2021-2026)
12.3.2 Europe: Immunology Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Immunology Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Immunology Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Immunology Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Immunology Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Immunology Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Immunology Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Immunology Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Immunology Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Immunology Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Immunology Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Immunology Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Immunology Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Immunology Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunology Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunology Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Immunology Drug Market Segments
Table 2. Ranking of Global Top Immunology Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immunology Drug Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies (mAb)
Table 5. Major Manufacturers of Antibody Drug Conjugates
Table 6. Major Manufacturers of Interferon and Cytokine therapies
Table 7. Major Manufacturers of Immunosuppressive medication
Table 8. Global Immunology Drug Market Size Growth Rate by Application 2020-2026 (MT)
Table 9. Global Immunology Drug Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 10. Global Immunology Drug Sales by Regions 2015-2020 (MT)
Table 11. Global Immunology Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Immunology Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Immunology Drug Sales by Manufacturers (2015-2020) (MT)
Table 14. Global Immunology Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Immunology Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Immunology Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunology Drug as of 2019)
Table 17. Immunology Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Immunology Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Immunology Drug Price (2015-2020) (USD/Kg)
Table 20. Immunology Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Immunology Drug Product Type
Table 22. Date of International Manufacturers Enter into Immunology Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunology Drug Sales by Type (2015-2020) (MT)
Table 25. Global Immunology Drug Sales Share by Type (2015-2020)
Table 26. Global Immunology Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Immunology Drug Revenue Share by Type (2015-2020)
Table 28. Immunology Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 29. Global Immunology Drug Sales by Application (2015-2020) (MT)
Table 30. Global Immunology Drug Sales Share by Application (2015-2020)
Table 31. North America Immunology Drug Sales by Country (2015-2020) (MT)
Table 32. North America Immunology Drug Sales Market Share by Country (2015-2020)
Table 33. North America Immunology Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Immunology Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Immunology Drug Sales by Type (2015-2020) (MT)
Table 36. North America Immunology Drug Sales Market Share by Type (2015-2020)
Table 37. North America Immunology Drug Sales by Application (2015-2020) (MT)
Table 38. North America Immunology Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Immunology Drug Sales by Country (2015-2020) (MT)
Table 40. Europe Immunology Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Immunology Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Immunology Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Immunology Drug Sales by Type (2015-2020) (MT)
Table 44. Europe Immunology Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Immunology Drug Sales by Application (2015-2020) (MT)
Table 46. Europe Immunology Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Immunology Drug Sales by Region (2015-2020) (MT)
Table 48. Asia Pacific Immunology Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Immunology Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Immunology Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Immunology Drug Sales by Type (2015-2020) (MT)
Table 52. Asia Pacific Immunology Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Immunology Drug Sales by Application (2015-2020) (MT)
Table 54. Asia Pacific Immunology Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Immunology Drug Sales by Country (2015-2020) (MT)
Table 56. Latin America Immunology Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Immunology Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Immunology Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Immunology Drug Sales by Type (2015-2020) (MT)
Table 60. Latin America Immunology Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Immunology Drug Sales by Application (2015-2020) (MT)
Table 62. Latin America Immunology Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Immunology Drug Sales by Country (2015-2020) (MT)
Table 64. Middle East and Africa Immunology Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Immunology Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Immunology Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Immunology Drug Sales by Type (2015-2020) (MT)
Table 68. Middle East and Africa Immunology Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Immunology Drug Sales by Application (2015-2020) (MT)
Table 70. Middle East and Africa Immunology Drug Sales Market Share by Application (2015-2020)
Table 71. Abbott Laboratories Corporation Information
Table 72. Abbott Laboratories Description and Major Businesses
Table 73. Abbott Laboratories Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 74. Abbott Laboratories Product
Table 75. Abbott Laboratories Recent Development
Table 76. Active Biotech Corporation Information
Table 77. Active Biotech Description and Major Businesses
Table 78. Active Biotech Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Active Biotech Product
Table 80. Active Biotech Recent Development
Table 81. Eli Lilly and Company Corporation Information
Table 82. Eli Lilly and Company Description and Major Businesses
Table 83. Eli Lilly and Company Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Eli Lilly and Company Product
Table 85. Eli Lilly and Company Recent Development
Table 86. Autoimmune Inc. Corporation Information
Table 87. Autoimmune Inc. Description and Major Businesses
Table 88. Autoimmune Inc. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Autoimmune Inc. Product
Table 90. Autoimmune Inc. Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Major Businesses
Table 93. Pfizer Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. GlaxoSmithKline plc Corporation Information
Table 97. GlaxoSmithKline plc Description and Major Businesses
Table 98. GlaxoSmithKline plc Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. GlaxoSmithKline plc Product
Table 100. GlaxoSmithKline plc Recent Development
Table 101. Seattle Genetics Corporation Information
Table 102. Seattle Genetics Description and Major Businesses
Table 103. Seattle Genetics Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Seattle Genetics Product
Table 105. Seattle Genetics Recent Development
Table 106. Genentech Corporation Information
Table 107. Genentech Description and Major Businesses
Table 108. Genentech Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Genentech Product
Table 110. Genentech Recent Development
Table 111. F. Hoffmann-La Roche Ltd. Corporation Information
Table 112. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 113. F. Hoffmann-La Roche Ltd. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. F. Hoffmann-La Roche Ltd. Product
Table 115. F. Hoffmann-La Roche Ltd. Recent Development
Table 116. Eisai Co. Corporation Information
Table 117. Eisai Co. Description and Major Businesses
Table 118. Eisai Co. Immunology Drug Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Eisai Co. Product
Table 120. Eisai Co. Recent Development
Table 121. Bayer AG Corporation Information
Table 122. Bayer AG Description and Major Businesses
Table 123. Bayer AG Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Bayer AG Product
Table 125. Bayer AG Recent Development
Table 126. Sanofi Aventis LLC. Corporation Information
Table 127. Sanofi Aventis LLC. Description and Major Businesses
Table 128. Sanofi Aventis LLC. Immunology Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 129. Sanofi Aventis LLC. Product
Table 130. Sanofi Aventis LLC. Recent Development
Table 131. Global Immunology Drug Sales Forecast by Regions (2021-2026) (MT)
Table 132. Global Immunology Drug Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Immunology Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Immunology Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Immunology Drug Sales Forecast by Country (2021-2026) (MT)
Table 136. North America: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Immunology Drug Sales Forecast by Country (2021-2026) (MT)
Table 138. Europe: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Immunology Drug Sales Forecast by Region (2021-2026) (MT)
Table 140. Asia Pacific: Immunology Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Immunology Drug Sales Forecast by Country (2021-2026) (MT)
Table 142. Latin America: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Immunology Drug Sales Forecast by Country (2021-2026) (MT)
Table 144. Middle East and Africa: Immunology Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Immunology Drug Players
Table 149. Immunology Drug Customers List
Table 150. Immunology Drug Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunology Drug Product Picture
Figure 2. Global Immunology Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies (mAb) Product Picture
Figure 4. Antibody Drug Conjugates Product Picture
Figure 5. Interferon and Cytokine therapies Product Picture
Figure 6. Immunosuppressive medication Product Picture
Figure 7. Global Immunology Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Cancer Research Centers and Institutes
Figure 11. Immunology Drug Report Years Considered
Figure 12. Global Immunology Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Immunology Drug Sales 2015-2026 (MT)
Figure 14. Global Immunology Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Immunology Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Immunology Drug Sales Market Share by Region in 2019
Figure 17. Global Immunology Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Immunology Drug Revenue Market Share by Region in 2019
Figure 19. Global Immunology Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Immunology Drug Revenue in 2019
Figure 21. Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Immunology Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Immunology Drug Sales Market Share by Type in 2019
Figure 24. Global Immunology Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Immunology Drug Revenue Market Share by Type in 2019
Figure 26. Global Immunology Drug Market Share by Price Range (2015-2020)
Figure 27. Global Immunology Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Immunology Drug Sales Market Share by Application in 2019
Figure 29. Global Immunology Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Immunology Drug Revenue Market Share by Application in 2019
Figure 31. North America Immunology Drug Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Immunology Drug Sales Market Share by Country in 2019
Figure 34. North America Immunology Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Immunology Drug Market Share by Type in 2019
Figure 40. North America Immunology Drug Market Share by Application in 2019
Figure 41. Europe Immunology Drug Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Immunology Drug Sales Market Share by Country in 2019
Figure 44. Europe Immunology Drug Revenue Market Share by Country in 2019
Figure 45. Germany Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 48. France Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Immunology Drug Market Share by Type in 2019
Figure 56. Europe Immunology Drug Market Share by Application in 2019
Figure 57. Asia Pacific Immunology Drug Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Immunology Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Immunology Drug Revenue Market Share by Region in 2019
Figure 61. China Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 62. China Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 68. India Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Immunology Drug Market Share by Type in 2019
Figure 84. Asia Pacific Immunology Drug Market Share by Application in 2019
Figure 85. Latin America Immunology Drug Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Immunology Drug Sales Market Share by Country in 2019
Figure 88. Latin America Immunology Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Immunology Drug Market Share by Type in 2019
Figure 96. Latin America Immunology Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Immunology Drug Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Immunology Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Immunology Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Immunology Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Immunology Drug Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Immunology Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Immunology Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Immunology Drug Market Share by Application in 2019
Figure 109. North America Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 110. North America Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. Europe Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Asia Pacific Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Latin America Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Immunology Drug Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Middle East and Africa Immunology Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
抗体薬物複合体（ADC）の世界市場（～2026年） Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased…- 免疫学の世界市場（～2026年） The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnor…
- 潰瘍性大腸炎免疫薬 の世界市場（～2026年） Market Analysis and Insights: Global Ulcerative Colitis Immunology Drugs Market The global Ulcerative Colitis Immunology Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ulcerative Colitis Immunology Drugs Scope a…
- ナノテクノロジードラッグデリバリーの世界市場（～2026年） Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e.…
- 高分子医薬品コンジュゲートの世界市場（～2026年） Market Analysis and Insights: Global Polymer Drug Conjugates Market The global Polymer Drug Conjugates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Polymer Drug Conjugates Scope and Market Size Polymer Drug Conjugat…